*** Welcome to piglix ***

Closed system drug transfer device


A closed system drug transfer device or "CSTD" is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system.

In response to the initial reports of occupationally linked cancer within the scientific community the surgeon, scientist and part-time inventor Dr. Bengt Gustavsson from Sahlgrenska University Hospital (Gothenburg, Sweden) designed the first completely sealed drug delivery system where hazardous drugs could be transferred from pharmacy to patient without leakage and/or atmospheric contamination.

The definition of a closed system drug transfer device was first published in an alert warning released by the American National Institute for Occupational Safety and Health (NIOSH). This warning was issued in relation to studies that showed a correlation between working with or near hazardous drugs in a health care environment and the increased risk of developing skin rashes, infertility, miscarriage and infant birth defects, as well as the possibility of developing leukemia and other forms of cancer. This NIOSH alert recommended that a closed system drug transfer device be used whenever hazardous drugs were to be handled.

NIOSH, in response to the need for a working model as to what a ‘closed system’ and what a ‘closed system drug transfer device’ was, provided the following definition:

The NIOSH definition is the only definition that includes drug vapors. NIOSH Considers the containment of vapor extremely important that in September 2015, NIOSH issued a Testing Protocol to assess the effectiveness of closed systems NIOSH developed and tested 5 CSTDs to assess its 'closeness.' 2 of the 5 CSTDs passed this testing while the other 3 failed. This protocol is aimed as being a test standard for Closed Systems to assess 'closeness' of each system.

ISOPP, the International Society of Oncology Pharmacy Practitioners splits the definition of a closed system into two different categories.

In September 2015, the CDC issued a proposal for a testing protocol designed to test various CSTDs on the market today to help healthcare decision makers decipher between various systems available on the market today. This protocol had an initial close date of November 2015 but was extended until March 2016. This period highlighted may opinions of what should be considered a closed system transfer device (Mechanical closure vs. filter based system) and led to several organizations commenting. Only 1 comment presented actual data based on testing performed after the comment period initiation. Below are the findings:


...
Wikipedia

...